Sideroblastic anemia medical therapy

Sideroblastic anemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Sideroblastic Anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Sideroblastic anemia medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sideroblastic anemia medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sideroblastic anemia medical therapy
CDC on Sideroblastic anemia medical therapy
Sideroblastic anemia medical therapy in the news
Blogs on Sideroblastic anemia medical therapy
Directions to Hospitals Treating Sideroblastic anemia
Risk calculators and risk factors for Sideroblastic anemia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The anemia can be so severe that support with transfusion is required. These patients usually do not respond to erythropoietin therapy.Some cases have been reported that the anemia is reversed or heme level is improved through use of moderate to high doses of Pyrodoxine (Vitamin B6.)

References

[Category:Disease]]